Carbonyl Cyanide m-Chlorophenylhydrazone a critical factor in the regulation of proton-selective ion channels to which OTOP2 belongs. Can lead to a compensatory upregulation of OTOP2 activity as the cell strives to restore ionic equilibrium.ZnCl2, may modulate OTOP2 indirectly through interaction with potential metal-binding domains that are often present in ion channels. This modulation could be a result of structural changes or alterations in the ionic environment surrounding OTOP2. In parallel, inhibitors of sodium transport such as amiloride, benzamil, and their derivatives, known for their blockade of epithelial sodium channels, might create a cellular context of altered sodium homeostasis, which could necessitate the engagement of OTOP2 to maintain pH balance.
Calcium channel antagonists such as verapamil, alongside gadolinium compounds used to block other types of ion channels, introduce changes in cellular ion homeostasis that are not directly linked to proton transport but may still require the action of OTOP2 to correct resultant dysregulation. Ouabain, a classic Na+/K+ ATPase inhibitor, and chloride channel blockers such as niflumic acid and IDRA 21, perturb the delicate balance of ions and pH, creating a scenario where OTOP2's regulatory activity becomes essential. Bafilomycin A1, a specific V-ATPase inhibitor, exemplifies a more direct approach to influencing intracellular proton concentrations, potentially triggering a cascade of events that lead to the activation of OTOP2 as the cell attempts to counteract the disruption. Cariporide and 5-(N-Ethyl-N-isopropyl)-Amiloride, both inhibitors of the Na+/H+ exchanger, underscore the importance of pH regulation to OTOP2's activity, as their action results in altered intracellular pH levels that may prompt OTOP2 to compensate as part of the cell's homeostatic response.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $75.00 $150.00 $235.00 | 8 | |
Uncouples oxidative phosphorylation, altering proton gradients which may indirectly affect OTOP2's proton channel activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Known to modulate various ion channels; could interact with the metal-binding sites on OTOP2, influencing its activity. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Blocks epithelial sodium channels and may indirectly influence ion transport and pH regulation involving OTOP2. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
L-type calcium channel blocker that could alter cellular ion homeostasis, potentially affecting OTOP2-related pathways. | ||||||
Gadolinium | 7440-54-2 | sc-250038 | 10 g | $87.00 | ||
Blocks certain types of ion channels; may affect OTOP2 activity by altering ion fluxes. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Inhibits Na+/K+ ATPase, affecting ionic gradients and potentially influencing proton channels including OTOP2. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $31.00 | 3 | |
Chloride channel blocker that may alter chloride and proton exchange, indirectly affecting OTOP2. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Specific inhibitor of the V-ATPase proton pump, altering intracellular proton concentrations and possibly affecting OTOP2. | ||||||
Benzamil•HCl | 161804-20-2 | sc-201070 | 50 mg | $195.00 | 1 | |
Derivative of amiloride that blocks sodium channels and could modulate ion transport related to OTOP2. | ||||||
Cariporide | 159138-80-4 | sc-337619A sc-337619 | 10 mg 100 mg | $85.00 $715.00 | 31 | |
Inhibitor of the Na+/H+ exchanger, could influence intracellular pH and indirectly affect OTOP2 activity. | ||||||